ID   TER259
AC   CVCL_E845
SY   TER-259; Ter-259; Ter 259; TER366; TER-366; Ter 366
DR   dbMHC; 49037
DR   IHW; IHW09401
DR   IPD-IMGT/HLA; 26005
DR   Wikidata; Q54972104
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*32:01,68:02; B*08:01,44:02:01:01; C*01:02,07; DPB1*03:01:01,04:01:01; DQA1*03:01,05:01; DQB1*02:01,03:02; DRB1*03:01,04:26; DRB3*01:01; DRB4*01:03 (IPD-IMGT/HLA=26005).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
RX   PubMed=30844424; DOI=10.1016/j.humimm.2019.03.001; PMCID=PMC6599558;
RA   Creary L.E., Guerra S.G., Chong W., Brown C.J., Turner T.R.,
RA   Robinson J., Bultitude W.P., Mayor N.P., Marsh S.G.E., Saito K.,
RA   Lam K., Duke J.L., Mosbruger T.L., Ferriola D., Monos D.S., Willis A.,
RA   Askar M., Fischer G.F., Saw C.L., Ragoussis J., Petrek M.,
RA   Serra-Pages C., Juan Otero M., Stavropoulos-Giokas C., Dinou A., Ameen R.,
RA   Al Shemmari S., Spierings E., Gendzekhadze K., Morris G.P., Zhang Q.-H.,
RA   Kashi Z., Hsu S., Gangavarapu S., Mallempati K.C., Yamamoto F.,
RA   Osoegawa K., Vayntrub T., Chang C.-J., Hansen J.A.,
RA   Fernandez-Vina M.A.;
RT   "Next-generation HLA typing of 382 International Histocompatibility
RT   Working Group reference B-lymphoblastoid cell lines: report from the
RT   17th International HLA and Immunogenetics Workshop.";
RL   Hum. Immunol. 80:449-460(2019).
//